U.S. Markets closed

FDA rules in favor of Lannett in dispute over cocaine product

John George
FDA rules in favor of Lannett in dispute over cocaine product

The federal agency's ruling means its review of Lannett's new drug application for a topical cocaine hydrocholride product can continue.